{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:05:51Z","timestamp":1776132351619,"version":"3.50.1"},"reference-count":87,"publisher":"Bentham Science Publishers Ltd.","issue":"13","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Aberrant expression of cell adhesion molecules and matrix metalloproteinase (MMPs) plays a pivotal role in\ntumor biological processes including progression and metastasis of cancer cells. Targeting these processes and detailed understanding of\ntheir underlying molecular mechanism is an essential step in cancer treatment. Dexamethasone (Dex) is a type of synthetic corticosteroid\nhormone used as adjuvant therapy in combination with current cancer treatments such as chemotherapy in order to alleviate its side\neffects like acute nausea and vomiting. Recent evidences have suggested that Dex may have antitumor characteristics.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Dex affects the migration and adhesion of T47D breast cancer cells as well as cell adhesion molecules e.g., cadherin and\nintegrin, and MMPs by regulating the expression levels of associated genes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> In this study, we evaluated the cytotoxicity of Dex on the T47D breast cancer cell line through MTT assay. Cell adhesion assay\nand wound healing assay were performed to determine the impact of Dex on cell adhesion and cell migration, respectively. Moreover,\nreal-time PCR was used to measure the levels of \u03b1 and \u03b2 integrin, E-cadherin, N-cadherin, MMP-2, and MMP-9.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Dex decreased the viability of T47D cells in a time and dose-dependent manner. Cell adhesion and migration of T47D cells were\nreduced upon Dex treatment. The expression of \u03b1 and \u03b2 integrin, E-cadherin, N-cadherin, MMP-2, and MMP-9 were altered in response\nto the Dex treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> Our findings demonstrated that Dex may have a role in the prevention of metastasis in this cell line.\n<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520621666201214150427","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T11:02:07Z","timestamp":1608030127000},"page":"2494-2501","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer\nCell Line"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0319-3066","authenticated-orcid":true,"given":"Leila","family":"Mohammadi","sequence":"first","affiliation":[{"name":"Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran"},{"name":"Department of Medical Biotechnology, Faculty\nof Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6661-0504","authenticated-orcid":true,"given":"Bashir","family":"Mosayyebi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Faculty\nof Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8524-8600","authenticated-orcid":true,"given":"Mahsa","family":"Imani","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Faculty\nof Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-3287","authenticated-orcid":true,"given":"Mohammad","family":"Rahmati","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Faculty\nof Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran"},{"name":"Drug Applied Research Center, Tabriz University\nof Medical Sciences, Tabriz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"15","volume":"6","author":"Chatterjee S.J.","year":"2014","unstructured":"Chatterjee S.J.; McCaffrey L.; Emerging role of cell polarity proteins in breast cancer progression and metastasis. Breast Cancer (Dove Med Press) 2014,6,15-27","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.31557\/APJCP.2019.20.7.2015","volume":"20","author":"Azamjah N.","year":"2019","unstructured":"Azamjah N.; Soltan-Zadeh Y.; Zayeri F.; \nGlobal trend of breast cancer mortality rate: a 25-year study. Asian Pacific journal of cancer prevention. Asian Pac J Cancer Prev 2019,20(7),2015-2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.20517\/2394-4722.2017.35","volume":"3","author":"Yagawa Y.","year":"2017","unstructured":"Yagawa Y.; Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery. J Cancer Metastasis Treat 2017,3(10),218","journal-title":"J Cancer Metastasis Treat"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"Fares J.","year":"2020","unstructured":"Fares J.; Fares M.Y.; Khachfe H.H.; Salhab H.A.; Fares Y.; Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 2020,5(1),28","journal-title":"Signal Transduct Target Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-018-0937-3","volume":"18","author":"S\u00f6keland G.","year":"2019","unstructured":"S\u00f6keland G.; Schumacher U.; The functional role of integrins during intra- and extravasation within the metastatic cascade. Mol Cancer 2019,18(1),12","journal-title":"Mol Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/676731","author":"Bendas G.","year":"2012","unstructured":"Bendas G.; Borsig L.; Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. International journal of cell biology 2012","journal-title":"International journal of cell biology"},{"key":"ref=7","author":"Lotfi M.","year":"2013","unstructured":"Lotfi M.; Naceur M.; Nejib M.;  Advances in Biomaterials Science and Biomedical Applications 2013","journal-title":"Advances in Biomaterials Science and Biomedical Applications"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","volume":"295","author":"Janiszewska M.","year":"2020","unstructured":"Janiszewska M.; Primi M.C.; Izard T.; Cell adhesion in cancer: Beyond the migration of single cells. J Biol Chem 2020,295(8),2495-2505","journal-title":"J Biol Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/jid.2008.461","volume":"129","author":"Kopecki Z.","year":"2009","unstructured":"Kopecki Z.; Arkell R.; Powell B.C.; Cowin A.J.; Flightless I regulates hemidesmosome formation and integrin-mediated cellular adhesion and migration during wound repair. J Invest Dermatol 2009,129(8),2031-2045","journal-title":"J Invest Dermatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"24103","DOI":"10.1074\/jbc.M112.360834","volume":"287","author":"Jeanes A.I.","year":"2012","unstructured":"Jeanes A.I.; Wang P.; Moreno-Layseca P.; Paul N.; Cheung J.; Tsang R.; Akhtar N.; Foster F.M.; Brennan K.; Streuli C.H.; Specific \u03b2-containing integrins exert differential control on proliferation and two-dimensional collective cell migration in mammary epithelial cells. J Biol Chem 2012,287(29),24103-24112","journal-title":"J Biol Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1186\/s40064-016-2502-0","volume":"5","author":"Pan L.","year":"2016","unstructured":"Pan L.; Zhao Y.; Yuan Z.; Qin G.; Research advances on structure and biological functions of integrins. Springerplus 2016,5(1),1094","journal-title":"Springerplus"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005074","volume":"3","author":"Huttenlocher A.","year":"2011","unstructured":"Huttenlocher A.; Horwitz A.R.; Integrins in cell migration. Cold Spring Harb Perspect Biol 2011,3(9)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1359\/jbmr.1997.12.8.1189","volume":"12","author":"Gronthos S.","year":"1997","unstructured":"Gronthos S.; Stewart K.; Graves S.E.; Hay S.; Simmons P.J.; Integrin expression and function on human osteoblast-like cells. J Bone Miner Res 1997,12(8),1189-1197","journal-title":"J Bone Miner Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1875-5364(19)30028-7","volume":"17","author":"Li Z.H.","year":"2019","unstructured":"Li Z.H.; Zhou Y.; Ding Y.X.; Guo Q.L.; Zhao L.; Roles of integrin in tumor development and the target inhibitors. Chin J Nat Med 2019,17(4),241-251","journal-title":"Chin J Nat Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1038\/sj.emboj.7601738","volume":"26","author":"Kren A.","year":"2007","unstructured":"Kren A.; Baeriswyl V.; Lehembre F.; Wunderlin C.; Strittmatter K.; Antoniadis H.; F\u00e4ssler R.; Cavallaro U.; Christofori G.; Increased tumor cell dissemination and cellular senescence in the absence of \u03b21-integrin function. EMBO J 2007,26(12),2832-2842","journal-title":"EMBO J"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"R626","DOI":"10.1016\/j.cub.2013.06.019","volume":"23","author":"Ma\u00eetre J-L.","year":"2013","unstructured":"Ma\u00eetre J-L.; Heisenberg C-P.; Three functions of cadherins in cell adhesion. Curr Biol 2013,23(14),R626-R633","journal-title":"Curr Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1242\/jcs.066654","volume":"125","author":"Saito M.","year":"2012","unstructured":"Saito M.; Tucker D.K.; Kohlhorst D.; Niessen C.M.; Kowalczyk A.P.; Classical and desmosomal cadherins at a glance. J Cell Sci 2012,125(Pt 11),2547-2552","journal-title":"J Cell Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"9857","DOI":"10.1073\/pnas.1019003108","volume":"108","author":"Kim S.A.","year":"2011","unstructured":"Kim S.A.; Tai C.Y.; Mok L.P.; Mosser E.A.; Schuman E.M.; Calcium-dependent dynamics of cadherin interactions at cell-cell junctions. Proc Natl Acad Sci USA 2011,108(24),9857-9862","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.scr.2015.02.002","volume":"14","author":"Alimperti S.","year":"2015","unstructured":"Alimperti S.; Andreadis S.T.; CDH2 and CDH11 act as regulators of stem cell fate decisions. Stem Cell Res (Amst) 2015,14(3),270-282","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ol.2015.3273","volume":"10","author":"Tian X.","year":"2015","unstructured":"Tian X.; Li Y.; Shen Y.; Li Q.; Wang Q.; Feng L.; Apoptosis and inhibition of proliferation of cancer cells induced by cordycepin. Oncol Lett 2015,10(2),595-599","journal-title":"Oncol Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"Loh C-Y.","year":"2019","unstructured":"Loh C-Y.; Chai J.Y.; Tang T.F.; Wong W.F.; Sethi G.; Shanmugam M.K.; Chong P.P.; Looi C.Y.; The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells 2019,8(10),1118","journal-title":"Cells"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/637308","volume":"2014","author":"Liu X.","year":"2014","unstructured":"Liu X.; Chu K-M.; E-cadherin and gastric cancer: cause, consequence, and applications. BioMed Res Int 2014,2014(12)","journal-title":"BioMed Res Int"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109320","volume":"118","author":"Cao Z-Q.","year":"2019","unstructured":"Cao Z-Q.; Wang Z.; Leng P.; Aberrant N-cadherin expression in cancer. Biomed Pharmacother 2019,118","journal-title":"Biomed Pharmacother"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.5604\/17322693.1009705","volume":"66","author":"Fink K.","year":"2012","unstructured":"Fink K.; Boraty\u0144ski J.; The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis. Postepy Hig Med Dosw 2012,66,609-628","journal-title":"Postepy Hig Med Dosw"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mce.2013.05.007","volume":"380","author":"Talab\u00e9r G.","year":"2013","unstructured":"Talab\u00e9r G.; Jondal M.; Okret S.; Extra-adrenal glucocorticoid synthesis: immune regulation and aspects on local organ homeostasis. Mol Cell Endocrinol 2013,380(1-2),89-98","journal-title":"Mol Cell Endocrinol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2215\/CJN.12991117","volume":"13","author":"Ponticelli C.","year":"2018","unstructured":"Ponticelli C.; Locatelli F.; Glucocorticoids in the treatment of glomerular diseases: pitfalls and pearls. Clin J Am Soc Nephrol 2018,13(5),815-822","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000362724","volume":"22","author":"Cruz-Topete D.","year":"2015","unstructured":"Cruz-Topete D.; Cidlowski J.A.; One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. Neuroimmunomodulation 2015,22(1-2),20-32","journal-title":"Neuroimmunomodulation"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"10245","DOI":"10.7314\/APJCP.2014.15.23.10245","volume":"15","author":"Meng X-G.","year":"2014","unstructured":"Meng X-G.; Yue S-W.; Dexamethasone disrupts cytoskeleton organization and migration of T47D Human breast cancer cells by modulating the AKT\/mTOR\/RhoA pathway. Asian Pac J Cancer Prev 2014,15(23),10245-10250","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1210\/me.2010-0402","volume":"25","author":"Molitoris J.K.","year":"2011","unstructured":"Molitoris J.K.; McColl K.S.; Distelhorst C.W.; Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol 2011,25(3),409-420","journal-title":"Mol Endocrinol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1517\/13543784.11.2.283","volume":"11","author":"Koutsilieris M.","year":"2002","unstructured":"Koutsilieris M.; Mitsiades C.; Dimopoulos T.; Vacalicos J.; Lambou T.; Tsintavis A.; Milathianakis C.; Bogdanos J.; Karamanolakis D.; Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer. Expert Opin Investig Drugs 2002,11(2),283-293","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/MMBR.00064-15","volume":"80","author":"Petta I.","year":"2016","unstructured":"Petta I.; Dejager L.; Ballegeer M.; Lievens S.; Tavernier J.; De Bosscher K.; Libert C.; The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases. Microbiol Mol Biol Rev 2016,80(2),495-522","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037030","volume":"7","author":"Li H.","year":"2012","unstructured":"Li H.; Qian W.; Weng X.; Wu Z.; Li H.; Zhuang Q.; Feng B.; Bian Y.; Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells. PLoS One 2012,7(6)","journal-title":"PLoS One"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/jcp.22383","volume":"226","author":"Yun S.P.","year":"2011","unstructured":"Yun S.P.; Ryu J.M.; Han H.J.; Involvement of \u03b21-integrin via PIP complex and FAK\/paxillin in dexamethasone-induced human mesenchymal stem cells migration. J Cell Physiol 2011,226(3),683-692","journal-title":"J Cell Physiol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4143\/crt.2015.209","volume":"48","author":"Han S.","year":"2016","unstructured":"Han S.; Dexamethasone Inhibits TGF-\u03b21-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61. Cancer research and treatment : official journal of Korean Cancer Association 2016,48(3),1141-1153","journal-title":"Cancer research and treatment : official journal of Korean Cancer Association"},{"key":"ref=35","first-page":"762","volume":"19","author":"Zhang D.","year":"2020","unstructured":"Zhang D.; Zhang Y.; Cai Z.; Tu Y.; Hu Z.; Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR\/AKT and VEGF signal pathways. Exp Ther Med 2020,19(1),762-770","journal-title":"Exp Ther Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.3892\/ol.2018.8269","volume":"15","author":"Guan Y.","year":"2018","unstructured":"Guan Y.; Chen J.; Zhan Y.; Lu H.; Effects of dexamethasone on C6 cell proliferation, migration and invasion through the upregulation of AQP1. Oncol Lett 2018,15(5),7595-7602","journal-title":"Oncol Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","volume":"18","author":"Seyfried T.N.","year":"2013","unstructured":"Seyfried T.N.; Huysentruyt L.C.; On the origin of cancer metastasis. Crit Rev Oncog 2013,18(1-2),43-73","journal-title":"Crit Rev Oncog"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13402-016-0281-9","volume":"39","author":"Paduch R.","year":"2016","unstructured":"Paduch R.; The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol (Dordr) 2016,39(5),397-410","journal-title":"Cell Oncol (Dordr)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","volume":"728","author":"van Zijl F.","year":"2011","unstructured":"van Zijl F.; Krupitza G.; Mikulits W.; Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 2011,728(1-2),23-34","journal-title":"Mutat Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/cr.2014.52","volume":"24","author":"He Y.","year":"2014","unstructured":"He Y.; Yi W.; Suino-Powell K.; Zhou X.E.; Tolbert W.D.; Tang X.; Yang J.; Yang H.; Shi J.; Hou L.; Jiang H.; Melcher K.; Xu H.E.; Structures and mechanism for the design of highly potent glucocorticoids. Cell Res 2014,24(6),713-726","journal-title":"Cell Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.aat.2011.06.002","volume":"49","author":"Ho C-M.","year":"2011","unstructured":"Ho C-M.; Wu H.L.; Ho S.T.; Wang J.J.; Dexamethasone prevents postoperative nausea and vomiting: benefit versus risk. Acta Anaesthesiol Taiwan 2011,49(3),100-104","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.01.050","volume":"1265","author":"Liu H.","year":"2009","unstructured":"Liu H.; Huang X.; Wang H.; Shen A.; Cheng C.; Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line. Brain Res 2009,1265,1-12","journal-title":"Brain Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.neuint.2013.07.007","volume":"63","author":"Leskiewicz M.","year":"2013","unstructured":"Leskiewicz M.; Jantas D.; Regulska M.; Kaczanowska J.; Basta-Kaim A.; Budziszewska B.; Kubera M.; Lason W.; Antidepressants attenuate the dexamethasone-induced decrease in viability and proliferation of human neuroblastoma SH-SY5Y cells: a involvement of extracellular regulated kinase (ERK1\/2). Neurochem Int 2013,63(5),354-362","journal-title":"Neurochem Int"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12640-009-9030-4","volume":"15","author":"Tazik S.","year":"2009","unstructured":"Tazik S.; Johnson S.; Lu D.; Johnson C.; Youdim M.B.; Stockmeier C.A.; Ou X.M.; Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis. Neurotox Res 2009,15(3),284-290","journal-title":"Neurotox Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1677\/ERC-08-0296","volume":"17","author":"Chen Y-X.","year":"2010","unstructured":"Chen Y-X.; Wang Y.; Fu C.C.; Diao F.; Song L.N.; Li Z.B.; Yang R.; Lu J.; Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells. Endocr Relat Cancer 2010,17(1),39-50","journal-title":"Endocr Relat Cancer"},{"key":"ref=46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135951","volume":"10","author":"Shannon S.","year":"2015","unstructured":"Shannon S.; Vaca C.; Jia D.; Entersz I.; Schaer A.; Carcione J.; Weaver M.; Avidar Y.; Pettit R.; Nair M.; Khan A.; Foty R.A.; Dexamethasone- mediated activation of fibronectin matrix assembly reduces dispersal of primary human glioblastoma cells. PLoS One 2015,10(8)","journal-title":"PLoS One"},{"key":"ref=47","first-page":"3380","volume":"17","author":"Huang G.X.","year":"2018","unstructured":"Huang G.X.; Qi M.F.; Li X.L.; Tang F.; Zhu L.; Involvement of upregulation of fibronectin in the pro-adhesive and pro-survival effects of glucocorticoid on melanoma cells. Mol Med Rep 2018,17(2),3380-3387","journal-title":"Mol Med Rep"},{"key":"ref=48","first-page":"767","volume":"32","author":"Bischofs E.","year":"2012","unstructured":"Bischofs E.; Lubs D.; Fritzsche F.; Meyer A.S.; Bruckner T.; Sohn C.; Eichbaum M.H.; In vitro blockade of adhesion of breast cancer cells to endothelial cells using anti-inflammatory drugs. Anticancer Res 2012,32(3),767-771","journal-title":"Anticancer Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.1038\/ncomms6917","volume":"6","author":"Lin K-T.","year":"2015","unstructured":"Lin K-T.; Yeh Y.M.; Chuang C.M.; Yang S.Y.; Chang J.W.; Sun S.P.; Wang Y.S.; Chao K.C.; Wang L.H.; Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nat Commun 2015,6(1),5917","journal-title":"Nat Commun"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4143\/crt.2015.209","volume":"48","author":"Han S.","year":"2016","unstructured":"Han S.; Dexamethasone inhibits TGF-\u03b21\u2013Induced cell migration by regulating the ERK and AKT pathways in human colon cancer cells via CYR61. Cancer Res Treatment 2016,48(3),1141","journal-title":"Cancer Res Treatment"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.3892\/mmr.2018.8566","volume":"17","author":"Guo J.","year":"2018","unstructured":"Guo J.; Ma K.; Xia H.M.; Chen Q.K.; Li L.; Deng J.; Sheng J.; Hong Y.Y.; Hu J.P.; Androgen receptor reverts dexamethasone-induced inhibition of prostate cancer cell proliferation and migration. Mol Med Rep 2018,17(4),5887-5893","journal-title":"Mol Med Rep"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"32483","DOI":"10.1074\/jbc.M109.014589","volume":"284","author":"Piette C.","year":"2009","unstructured":"Piette C.; Deprez M.; Roger T.; No\u00ebl A.; Foidart J.M.; Munaut C.; The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors. J Biol Chem 2009,284(47),32483-32492","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/ijc.31132","volume":"142","author":"Kostopoulou O.N.","year":"2018","unstructured":"Kostopoulou O.N.; Mohammad A.A.; Bartek J.; Winter J.; Jung M.; Stragliotto G.; S\u00f6derberg-Naucl\u00e9r C.; Land\u00e1zuri N.; Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance. Int J Cancer 2018,142(6),1266-1276","journal-title":"Int J Cancer"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","volume":"10","author":"Harjunp\u00e4\u00e4 H.","year":"2019","unstructured":"Harjunp\u00e4\u00e4 H.; Llort Asens M.; Guenther C.; Fagerholm S.C.; Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol 2019,10,1078","journal-title":"Front Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1096\/fj.14-261586","volume":"29","author":"McNeill B.","year":"2015","unstructured":"McNeill B.; Vulesevic B.; Ostojic A.; Ruel M.; Suuronen E.J.; Collagen matrix-induced expression of integrin \u03b1V\u03b23 in circulating angiogenic cells can be targeted by matricellular protein CCN1 to enhance their function. FASEB J 2015,29(4),1198-1207","journal-title":"FASEB J"},{"key":"ref=56","first-page":"79","volume":"25","author":"Takayama S.","year":"2005","unstructured":"Takayama S.; Ishii S.; Ikeda T.; Masamura S.; Doi M.; Kitajima M.; The relationship between bone metastasis from human breast cancer and integrin \u03b1(v)\u03b23 expression. Anticancer Res 2005,25(1A),79-83","journal-title":"Anticancer Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/sj.gt.3301887","volume":"10","author":"Br\u00fcning A.","year":"2003","unstructured":"Br\u00fcning A.; Runnebaum I.B.; CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther 2003,10(3),198-205","journal-title":"Gene Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1016\/j.bbamcr.2013.09.020","volume":"1833","author":"Faralli J.A.","year":"2013","unstructured":"Faralli J.A.; Gagen D.; Filla M.S.; Crotti T.N.; Peters D.M.; Dexamethasone increases \u03b1v\u03b23 integrin expression and affinity through a calcineurin\/NFAT pathway. Biochim Biophys Acta 2013,1833(12),3306-3313","journal-title":"Biochim Biophys Acta"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6","volume":"77","author":"Cheng S.L.","year":"2000","unstructured":"Cheng S.L.; Lai C.F.; Fausto A.; Chellaiah M.; Feng X.; McHugh K.P.; Teitelbaum S.L.; Civitelli R.; Hruska K.A.; Ross F.P.; Avioli L.V.; Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells. J Cell Biochem 2000,77(2),265-276","journal-title":"J Cell Biochem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/cr.2017.108","volume":"27","author":"Wu D.","year":"2017","unstructured":"Wu D.; Xu Y.; Ding T.; Zu Y.; Yang C.; Yu L.; Pairing of integrins with ECM proteins determines migrasome formation. Cell Res 2017,27(11),1397-1400","journal-title":"Cell Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1158\/0008-5472.CAN-04-0069","volume":"64","author":"Jia Y.","year":"2004","unstructured":"Jia Y.; Integrin fibronectin receptors in matrix metalloproteinase-1\u2013dependent invasion by breast cancer and mammary epithelial cells. 2004,64(23),8674-8681"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/sj.onc.1208423","volume":"24","author":"Maschler S.","year":"2005","unstructured":"Maschler S.; Tumor cell invasiveness correlates with changes in integrin expression and localization. 2005,24(12),2032-2041"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.omtn.2019.05.006","volume":"17","author":"Fechter P.","year":"2019","unstructured":"Fechter P.; Cruz Da Silva E.; Mercier M.C.; Noulet F.; Etienne-Seloum N.; Guenot D.; Lehmann M.; Vauchelles R.; Martin S.; Lelong-Rebel I.; Ray A.M.; Seguin C.; Dontenwill M.; Choulier L.; RNA aptamers targeting integrin \u03b15\u03b21 as probes for cyto- and histofluorescence in glioblastoma. Mol Ther Nucleic Acids 2019,17,63-77","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/JME-15-0142","volume":"57","author":"Yin L.","year":"2016","unstructured":"Yin L.; Fang F.; Song X.; Wang Y.; Huang G.; Su J.; Hui N.; Lu J.; The pro-adhesive and pro-survival effects of glucocorticoid in human ovarian cancer cells. J Mol Endocrinol 2016,57(1),61-72","journal-title":"J Mol Endocrinol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"7457","DOI":"10.3748\/wjg.v21.i24.7457","volume":"21","author":"Yang G-Y.","year":"2015","unstructured":"Yang G-Y.; Guo S.; Dong C.Y.; Wang X.Q.; Hu B.Y.; Liu Y.F.; Chen Y.W.; Niu J.; Dong J.H.; Integrin \u03b1v\u03b26 sustains and promotes tumor invasive growth in colon cancer progression. World J Gastroenterol 2015,21(24),7457-7467","journal-title":"World J Gastroenterol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/carcin\/23.2.237","volume":"23","author":"Ahmed N.","year":"2002","unstructured":"Ahmed N.; Pansino F.; Clyde R.; Murthi P.; Quinn M.A.; Rice G.E.; Agrez M.V.; Mok S.; Baker M.S.; Overexpression of \u03b1(v)\u03b26 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis 2002,23(2),237-244","journal-title":"Carcinogenesis"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2174\/138945009788680374","volume":"10","author":"Bandyopadhyay A.","year":"2009","unstructured":"Bandyopadhyay A.; Raghavan S.; Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets 2009,10(7),645-652","journal-title":"Curr Drug Targets"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3892\/ijo.2013.2097","volume":"43","author":"Kwon J.","year":"2013","unstructured":"Kwon J.; Lee T.S.; Lee H.W.; Kang M.C.; Yoon H.J.; Kim J.H.; Park J.H.; Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma. Int J Oncol 2013,43(5),1523-1530","journal-title":"Int J Oncol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1074\/jbc.M803997200","volume":"284","author":"Chen M.","year":"2009","unstructured":"Chen M.; Sinha M.; Luxon B.A.; Bresnick A.R.; O\u2019Connor K.L.; Integrin \u03b16\u03b24 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4\/metastasin. J Biol Chem 2009,284(3),1484-1494","journal-title":"J Biol Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.omto.2019.04.005","volume":"14","author":"Song Y.","year":"2019","unstructured":"Song Y.; Ye M.; Zhou J.; Wang Z.W.; Zhu X.; Restoring E-cadherin expression by natural compounds for anticancer therapies in genital and urinary cancers. Mol Ther Oncolytics 2019,14,130-138","journal-title":"Mol Ther Oncolytics"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3389\/fonc.2019.00989","volume":"9","author":"Yu W.","year":"2019","unstructured":"Yu W.; Yang L.; Li T.; Zhang Y.; Cadherin Signaling in Cancer: Its Functions and Role as a Therapeutic Target. Front Oncol 2019,9,989","journal-title":"Front Oncol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","volume":"37","author":"Mendonsa A.M.","year":"2018","unstructured":"Mendonsa A.M.; Na T-Y.; Gumbiner B.M.; E-cadherin in contact inhibition and cancer. Oncogene 2018,37(35),4769-4780","journal-title":"Oncogene"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/cancers10120484","volume":"10","author":"Ide H.","year":"2018","unstructured":"Ide H.; Inoue S.; Miyamoto H.; The role of glucocorticoid receptor signaling in bladder cancer progression. Cancers (Basel) 2018,10(12),484","journal-title":"Cancers (Basel)"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/cells9020367","volume":"9","author":"Melnik D.","year":"2020","unstructured":"Melnik D.; Sahana J.; Corydon T.J.; Kopp S.; Nassef M.Z.; Wehland M.; Infanger M.; Grimm D.; Kr\u00fcger M.; Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity. Cells 2020,9(2),367","journal-title":"Cells"},{"key":"ref=75","author":"Nguyen T.M.","year":"2020","unstructured":"Nguyen T.M.; Zhang Y.; Pandolfi P.P.;  Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses 2020","journal-title":"Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ajhg.2019.09.005","volume":"105","author":"Accogli A.","year":"2019","unstructured":"Accogli A.; Calabretta S.; St-Onge J.; Boudrahem-Addour N.; Dionne-Laporte A.; Joset P.; Azzarello-Burri S.; Rauch A.; Krier J.; Fieg E.; Pallais J.C.; McConkie-Rosell A.; McDonald M.; Freedman S.F.; Rivi\u00e8re J.B.; Lafond-Lapalme J.; Simpson B.N.; Hopkin R.J.; Trimouille A.; Van-Gils J.; Begtrup A.; McWalter K.; Delphine H.; Keren B.; Genevieve D.; Argilli E.; Sherr E.H.; Severino M.; Rouleau G.A.; Yam P.T.; Charron F.; Srour M.; De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects. Am J Hum Genet Undiagnosed Diseases Network2019,105(4),854-868","journal-title":"Am J Hum Genet"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.3390\/ijms20133373","volume":"20","author":"Casal J.I.","year":"2019","unstructured":"Casal J.I.; Bartolom\u00e9 R.A.; Beyond N-cadherin, relevance of cadherins 5, 6 and 17 in cancer progression and metastasis. Int J Mol Sci 2019,20(13),3373","journal-title":"Int J Mol Sci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/(SICI)1097-4644(20000601)77:3<499::AID-JCB14>3.0.CO;2-0","volume":"77","author":"Lecanda F.","year":"2000","unstructured":"Lecanda F.; Cheng S.L.; Shin C.S.; Davidson M.K.; Warlow P.; Avioli L.V.; Civitelli R.; Differential regulation of cadherins by dexamethasone in human osteoblastic cells. J Cell Biochem 2000,77(3),499-506","journal-title":"J Cell Biochem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/cancers6010366","volume":"6","author":"Said A.H.","year":"2014","unstructured":"Said A.H.; Raufman J-P.; Xie G.; The role of matrix metalloproteinases in colorectal cancer. Cancers (Basel) 2014,6(1),366-375","journal-title":"Cancers (Basel)"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/bjc.2017.362","volume":"117","author":"Yu C-F.","year":"2017","unstructured":"Yu C-F.; Chen F.H.; Lu M.H.; Hong J.H.; Chiang C.S.; Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion. Br J Cancer 2017,117(12),1828-1836","journal-title":"Br J Cancer"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.3892\/mmr.2017.7634","volume":"16","author":"Cai X.","year":"2017","unstructured":"Cai X.; Zhu H.; Li Y.; PKC\u03b6, MMP\u20112 and MMP\u20119 expression in lung adenocarcinoma and association with a metastatic phenotype. Mol Med Rep 2017,16(6),8301-8306","journal-title":"Mol Med Rep"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3892\/or.2015.4292","volume":"34","author":"Lee C-S.","year":"2015","unstructured":"Lee C-S.; Cho H.J.; Jeong Y.J.; Shin J.M.; Park K.K.; Park Y.Y.; Bae Y.S.; Chung I.K.; Kim M.; Kim C.H.; Jin F.; Chang H.W.; Chang Y.C.; Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK\/JNK-mediated MMP-9 expression. Oncol Rep 2015,34(6),2901-2908","journal-title":"Oncol Rep"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3892\/ijo.8.2.327","volume":"8","author":"Hirata M.","year":"1996","unstructured":"Hirata M.; Itoh M.; Tsuchida A.; Ooishi H.; Hanada K.; Kajiyama G.; Dexamethasone inhibits invasiveness of a human pancreatic cancer cell line. Int J Oncol 1996,8(2),327-330","journal-title":"Int J Oncol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3892\/ijo.2013.2113","volume":"43","author":"Roomi M.W.","year":"2013","unstructured":"Roomi M.W.; Kalinovsky T.; Monterrey J.; Rath M.; Niedzwiecki A.; In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol 2013,43(6),1787-1798","journal-title":"Int J Oncol"},{"key":"ref=85","author":"Vu H.T.","year":"2018","unstructured":"Vu H.T.; Hoang T.X.; Kim J.Y.; All-trans retinoic acid enhances matrix metalloproteinase 2 expression and secretion in human myeloid leukemia THP-1 cells. BioMed Research International 2018","journal-title":"BioMed Research International"},{"key":"ref=86","author":"Alexandra F.","year":"2012","unstructured":"Alexandra F.; Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma. 2012"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.3892\/or.2017.5597","volume":"37","author":"Roomi M.W.","year":"2017","unstructured":"Roomi M.W.; Kalinovsky T.; Niedzwiecki A.; Rath M.; Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells. Oncol Rep 2017,37(6),3681-3687","journal-title":"Oncol Rep"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666201214150427","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/189120\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666201214150427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T14:45:05Z","timestamp":1691678705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/189120\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":87,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520621666201214150427","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}